The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects
Status:
Completed
Trial end date:
2020-08-27
Target enrollment:
Participant gender:
Summary
A Phase Ib/IIa, Single Center, Randomized, open, Sofosbuvir-controlled, Multiple Ascending
Dose Study to Access the Tolerability，Pharmacokinetics and Pharmacodynamics of HEC110114
Tablets in HCV-infected Subjects